Patient Leaflet Updated 30-Jul-2020 | Almirall Limited
Curatoderm Ointment
Curatoderm® 4 micrograms/g Ointment
Tacalcitol
1. What Curatoderm Ointment is and what it is used for
2. What you need to know before you use Curatoderm Ointment
3. How to use Curatoderm Ointment
4. Possible side effects
5. How to store Curatoderm Ointment
6. Contents of the pack and other information
Curatoderm Ointment contains tacalcitol which is a drug that belongs to a group of medicines called antipsoriatics and is a vitamin D derivative.
Curatoderm Ointment is used to treat a condition known as psoriasis vulgaris. Psoriasis is a skin disorder in which itchy, red, flaky patches appear on the skin or scalp. Within affected areas of skin, new cells are being produced faster than normal, but old dead cells are only being shed at the normal rate. As live skin cells accumulate, the skin becomes thickened and inflamed.
Curatoderm Ointment works by slowing down cell production and bringing it back to normal and helps reduce inflammation.
If this applies to you do not use this medicine and speak to your doctor.
When applying Curatoderm Ointment to the face: Do not allow the Ointment to come in contact with the eyes. If it does, rinse thoroughly with water.
Talk to your doctor before using Curatoderm Ointment if
Your doctor may want to check the level of calcium in your blood if you have any of these conditions.
Do not smoke or go near naked flames - risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns more easily and is a serious fire hazard. Washing clothing and bedding may reduce product build-up but not totally remove it.
The safety and efficacy of Curatoderm Ointment in children and adolescents under 18 years have not been established.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.
Especially:
If you are receiving ultraviolet (UV) therapy, this should be given in the morning and Curatoderm Ointment used at bedtime.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
The potential risk to the baby if Curatoderm Ointment is used during pregnancy is unknown. Therefore if you are pregnant or likely to become pregnant whilst using Curatoderm Ointment make sure your doctor knows.
It is not known if Curatoderm Ointment passes into breast milk. Only a small amount is absorbed into the body after skin treatment. It is probably not necessary to stop breast-feeding during treatment.
If the breast area is affected by psoriasis, it is recommended that the breast area is not treated with Curatoderm Ointment or breast-feeding should be stopped. Discuss this with your doctor.
Curatoderm Ointment is not expected to have any effect on your ability to drive or use machines.
Butylhydroxytoluene may cause local skin reactions (e.g. contact dermatitis), or irritation to the eyes and mucous membranes.
Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
Curatoderm Ointment is not recommended for use in children, as there is limited experience. Curatoderm Ointment is for use by adults including the elderly.
Curatoderm Ointment can be used on all areas of the body including face, hairline, scalp, armpits, elbows and knees.
Follow your doctor’s instructions for use exactly. The following are general guidelines:
It is important to tell your doctor if you have used too much Curatoderm Ointment, as it may be necessary to check the amount of calcium in your blood.
If you forget to use Curatoderm Ointment at the usual time, use it as soon as you remember, then carry on as before. Do not apply two doses at the same time.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
These are usually mild effects and don’t last very long.
The following side effects have also been reported (frequency not known, cannot be estimated from the available data):
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Curatoderm Ointment should be stored below 30°C.
Do not use this medicine after the expiry date which is stated on the label after “EXP:”.
The expiry date refers to the last day of that month.
Do not use for longer than 6 months after first opening the tube.
Medicines should not be disposed of via waste water or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
The active substance is tacalcitol
There are 4 micrograms of tacalcitol (the active ingredient) in each gram of ointment
The other ingredients are paraffin, white soft (contains butylhydroxytoluene E321), liquid paraffin and diisopropyl adipate.
Curatoderm Ointment is a translucent and white, glossy ointment.
Your medicinal product comes in either 5g, 20g, 30g or 100g aluminium tubes with a screw cap.
Not all pack sizes may be marketed.
This leaflet was last revised in: 05/2020
Almirall Limited, Harman House, 1 George Street, Uxbridge, Middlesex, UB8 1QQ, UK
0800 0087399
